Skip to content

Labor induction

A comparison between the effect of oral titrated solution of misoprostol and intravenous oxitocine for labor induction in term pregnancies.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201403242624N13
Enrollment
80
Registered
2014-09-09
Start date
2014-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: cervical ripening. Condition 2: induction of labor. Condition 3: medical induction of labour. Condition 4: Delivery. Maternal care related to the fetus and amniotic cavity and possible delivery problems Complications of labour and delivery. Failed medical induction of labour Delivery

Interventions

Intervention 1: administration of oral titrated solution of misoprostol. 200 microgram misoprostol will be solved in 200 mili liter water, and 20 cc of this solution will be prescribed every 2 hours
Treatment - Drugs
administration of oral titrated solution of misoprostol. 200 microgram misoprostol will be solved in 200 mili liter water, and 20 cc of this solution will be prescribed every 2 hours. ( maximum 60 m
infusion of 2.5 mili units oxitocine per minute that will be doubled every 15 minutes. Maximum dose of oxitocine is 60 mili units per minute.

Sponsors

Vice chancellor for research ,Iran University of Medical Sciences.
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 20-40 year old; reliable gestational age between 40-42 weeks; singleton pregnancy with cephalic presentation; BISHOP Score of more than 5; favorable pelvis. Exclusion criteria: parity of more than 3, blood pressure equal or more than 160/110 mmHg; abnormal NST and any sign of fetal distress; urine protein of more than 2 gram in 24 hours; suspicious for HELLP syndrome; poly hydramnios; probable macrosomia; any vaginal bleeding; history of any surgery on uterus; prostaglandin use during present pregnancy and beginning of spontaneous uterine contractions.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Number of deliveries during the first 24 hours. Timepoint: 24 hours. Method of measurement: Data sheets.

Secondary

MeasureTime frame
Rout of delivery. Timepoint: ---. Method of measurement: data sheets.;Uterine hyperstimulation. Timepoint: every 30 minutes. Method of measurement: monitoring of uterine contractions- tocography.;Fetal distress. Timepoint: every 15 minutes. Method of measurement: fetal heart rate monitoring with tococardiography.;Neonatal Apgar Score. Timepoint: minute 1 and 5. Method of measurement: data sheets.;Number of deliveries during 6-12-18 hours from the beginning of induction. Timepoint: 6-12-18 hours from the beginning of induction. Method of measurement: data sheets.;Duration of stage 1 , 2 and 3 of labor. Timepoint: end of stage 1 , 2 and 3 of labor. Method of measurement: data sheets.;Interval between the beginning of induction up to the beginning of suitable contractions( 3 forceful contractions during 10 minutes). Timepoint: every 30 minutes. Method of measurement: data sheets.;Indications for cesarean deliveries. Timepoint: during cesarean deliveries. Method of measurement: data sheets.;NICU admission. Timepoint: After birth up to discharge. Method of measurement: data sheets.;Duration of hospital stay for mother and baby. Timepoint: admission , discharge. Method of measurement: data sheets.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Kashanian

Iran University of Medical Sciences

maryamkashanian@yahoo.com+98 21 5563 3244

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026